SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005201-19-000019
Filing Date
2019-02-14
Accepted
2019-02-14 16:19:04
Documents
2
Period of Report
2019-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_155017913104480.html 4  
1 FORM 4 wf-form4_155017913104480.xml 4 6975
2 BUKOFZER POA ex-24.htm EX-24 3131
  Complete submission text file 0001005201-19-000019.txt   11612
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Issuer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O OCERA THERAPEUTICS 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301
Business Address
Bukofzer Stan (Reporting) CIK: 0001663041 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13111 | Film No.: 19606640